The measure should account for patients with ocular conditions that impact case complexity to account for patient heterogeneity
Drugs and biological products for which the Medicare Part B average total allowed charges for a year per individual that uses such drug or biological are below the applicable threshold, as described in paragraph (c) of this section
multiple trajectories for multiple or complex lesion(s) ), as the RUC-recommended work value implies
What coordination, if any, occurs between the medical and dental professionals
* * * * * (iv) * * * (B) Beginning with the 2021 MIPS payment year, except as provided for in paragraph (b)(1)(iv)(C) of this section, each measure (except for measures in the CMS Web Interface) for which the benchmark for the applicable collection type is identified as topped out for 2 or more consecutive years receives no more than 7 measure achievement points in the second consecutive year it is identified as topped out, and beyond
Small intestine bacterial overgrowth (SIBO)
